APA

Attenberger U. I., Ong M. M., Rathmann N., Doyon F., Kienle P., Hofheinz R., Pilz L. R., Dinter D. J., Schoenberg S. O. & Hausmann D. (20170127). mMRI at 3.0 T as an Evaluation Tool of Therapeutic Response to Neoadjuvant CRT in Patients with Advanced-stage Rectal Cancer. : Anticancer research.

Chicago

Attenberger Ulrike I, Ong Melissa M, Rathmann Nils, Doyon Fabian, Kienle Peter, Hofheinz Ralf-Dieter, Pilz Lothar R, Dinter Dietmar J, Schoenberg Stefan O and Hausmann Daniel. 20170127. mMRI at 3.0 T as an Evaluation Tool of Therapeutic Response to Neoadjuvant CRT in Patients with Advanced-stage Rectal Cancer. : Anticancer research.

Harvard

Attenberger U. I., Ong M. M., Rathmann N., Doyon F., Kienle P., Hofheinz R., Pilz L. R., Dinter D. J., Schoenberg S. O. and Hausmann D. (20170127). mMRI at 3.0 T as an Evaluation Tool of Therapeutic Response to Neoadjuvant CRT in Patients with Advanced-stage Rectal Cancer. : Anticancer research.

MLA

Attenberger Ulrike I, Ong Melissa M, Rathmann Nils, Doyon Fabian, Kienle Peter, Hofheinz Ralf-Dieter, Pilz Lothar R, Dinter Dietmar J, Schoenberg Stefan O and Hausmann Daniel. mMRI at 3.0 T as an Evaluation Tool of Therapeutic Response to Neoadjuvant CRT in Patients with Advanced-stage Rectal Cancer. : Anticancer research. 20170127.